Cybin (FRA:R7E1) ROCE % : -126.96% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Cybin ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Cybin's annualized ROCE % for the quarter that ended in Dec. 2023 was -126.96%.

Cybin ROCE % Historical Data

The historical data trend for Cybin's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin ROCE % Chart

Cybin Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

ROCE %

-72.69

-81.11

-80.34

Cybin Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial										-76.59	-103.84	-116.74	-126.16	-126.96

Cybin ROCE % Calculation

Cybin's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	-35.166	/	( ( (60.292 - 5.672)	+	(36.79 - 3.866) )	/ 2 )
	=	-35.166	/	( (54.62	+	32.924)	/ 2 )
	=	-35.166	/	43.772
	=	-80.34 %

Cybin's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-73.884	/	( ( (39.906 - 6.401)	+	(88.668 - 5.783) )	/ 2 )
	=	-73.884	/	( ( 33.505	+	82.885 )	/ 2 )
	=	-73.884	/	58.195
	=	-126.96 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Cybin (FRA:R7E1) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Cybin ROCE % Related Terms

Thank you for viewing the detailed overview of Cybin's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cybin (FRA:R7E1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (FRA:R7E1) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

CYBN:USA R7E1:Germany CYBN:Canada

Address

100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9

Website

https://www.cybin.com

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.

Cybin (FRA:R7E1) Headlines

No Headlines